The shortcomings of tocilizumab in COVID-19

Infez Med. 2020 Dec 1;28(4):465-468.

¹ Department of Medicine, Penn State University School of Medicine, Hershey, PA, USA; Keystone Infectious Diseases/HIV, Keystone Health, Chambersburg, PA, USA; Department of Medicine, Wellspan Chambersburg and Waynesboro Hospitals, Chambersburg, PA, USA.
² Vydehi Institute of Medical Sciences and Research Center, Bangalore, India.
³ Department of Medicine, Wellspan Chambersburg and Waynesboro Hospitals, Chambersburg, PA, USA.
⁴ Department of Psychiatry, Keystone Health, Chambersburg, PA, USA.
⁵ Department of Nephrology, University of Mississippi Medical Center, Jackson, MS, USA.
⁶ Molecular Diagnostic Laboratory, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia; Specialty Internal Medicine and Quality Department, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia; Infectious Disease Division, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Abstract

Not available.